Pressure-Fracture Competition Regime Map for ASD Manufacturing Optimization

Many of today's most promising medicines have a frustrating problem: they don't dissolve well in the body. Pharmaceutical scientists tackle this by turning drugs into a special glassy, disordered form mixed with a polymer — called an amorphous solid dispersion, or ASD. Think of it like mixing sugar into a glass of water versus leaving sugar crystals intact; the dissolved form releases much faster. But predicting exactly *how fast* an ASD releases its drug, and why that changes depending on how much drug is packed in, has been surprisingly tricky. This hypothesis borrows a mathematical framework originally developed to understand how volcanic glass dissolves in seawater over geological timescales. Geochemists use something called Transition State Theory to describe the rate at which minerals break down — tracking the energy barriers molecules must overcome at the surface before dissolving. The proposal here is that the same equations, with the same physical logic, can describe drug-polymer glasses dissolving in stomach fluid. Specifically, it suggests there's a critical threshold around 25% drug content: below that, dissolution is controlled by the drug-polymer bond-breaking at the surface (where the volcanic glass math applies beautifully); above it, the process is instead bottlenecked by how fast dissolved drug can physically diffuse away — a completely different regime requiring different equations. The clever part is a diagnostic number — borrowed from chemical engineering — called a Damköhler number, which tells you which regime you're in before you even run an experiment. If confirmed, this would give pharmaceutical scientists a principled, predictive tool rather than a trial-and-error approach to figuring out why a drug formulation releases too fast, too slow, or inconsistently.

This is an AI-generated summary. Read the full mechanism below for technical detail.